Clinical Focus ›› 2024, Vol. 39 ›› Issue (4): 332-336.doi: 10.3969/j.issn.1004-583X.2024.04.006
Previous Articles Next Articles
Wang Chunjie, Xie Jing, Han Xue, Wu Dan, Chen Jianhua()
Received:
2023-10-20
Online:
2024-04-20
Published:
2024-06-28
Contact:
Chen Jianhua, Email: CLC Number:
Wang Chunjie, Xie Jing, Han Xue, Wu Dan, Chen Jianhua. Effect of individualized hemodialysis on dialysis complications in elderly patients with diabetic nephropathy[J]. Clinical Focus, 2024, 39(4): 332-336.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2024.04.006
组别 | 例数 | 性别[例(%)] | 年龄 (岁) | 透析时间 (月) | |
---|---|---|---|---|---|
男性 | 女性 | ||||
DN1组 | 20 | 9(45.0) | 11(55.0) | 64.20±5.81 | 7.30±2.30 |
DN2组 | 20 | 9(45.0) | 11(55.0) | 64.55±3.85 | 7.03±2.28 |
NDN1组 | 20 | 12(60.0) | 8(40.0) | 68.90±5.55 | 7.27±2.52 |
NDN2组 | 20 | 11(55.0) | 9(45.0) | 65.60±3.70 | 7.48±2.40 |
统计值 | χ2=1.114 | ||||
0.142 | 0.071 | 0.162 |
Tab.1 Comparison of general data between groups
组别 | 例数 | 性别[例(%)] | 年龄 (岁) | 透析时间 (月) | |
---|---|---|---|---|---|
男性 | 女性 | ||||
DN1组 | 20 | 9(45.0) | 11(55.0) | 64.20±5.81 | 7.30±2.30 |
DN2组 | 20 | 9(45.0) | 11(55.0) | 64.55±3.85 | 7.03±2.28 |
NDN1组 | 20 | 12(60.0) | 8(40.0) | 68.90±5.55 | 7.27±2.52 |
NDN2组 | 20 | 11(55.0) | 9(45.0) | 65.60±3.70 | 7.48±2.40 |
统计值 | χ2=1.114 | ||||
0.142 | 0.071 | 0.162 |
组别 | 例数 | 低血压 | 低血糖 | 肢体痉挛 | 高血压 |
---|---|---|---|---|---|
DN1组 | 20 | 11.0(10.0, 15.8) | 5.0(4.0, 6.8) | 3.0(2.0, 5.8) | 10.0(2.0, 22.8) |
NDN1组 | 20 | 3.5(2.3, 6.8) | 0.0(0.0, 0.8) | 0.0(0.0, 1.0) | 5.5(4.0, 16.0) |
-4.531 | -4.984 | -4.446 | -0.761 | ||
<0.01 | <0.01 | <0.01 | 0.447 |
Tab.2 Frequency of complications in elderly dialysis patients with individualized hemodialysis regimens ( M [P25, P75])
组别 | 例数 | 低血压 | 低血糖 | 肢体痉挛 | 高血压 |
---|---|---|---|---|---|
DN1组 | 20 | 11.0(10.0, 15.8) | 5.0(4.0, 6.8) | 3.0(2.0, 5.8) | 10.0(2.0, 22.8) |
NDN1组 | 20 | 3.5(2.3, 6.8) | 0.0(0.0, 0.8) | 0.0(0.0, 1.0) | 5.5(4.0, 16.0) |
-4.531 | -4.984 | -4.446 | -0.761 | ||
<0.01 | <0.01 | <0.01 | 0.447 |
组别 | 例数 | 低血压 | 低血糖 | 肢体痉挛 | 高血压 |
---|---|---|---|---|---|
DN2组 | 20 | 19.5(16.5, 26.8) | 11.5(8.3, 13.0) | 9.5(8.0, 11.0) | 18.0(8.0, 35.5) |
NDN2组 | 20 | 9.5(6.0, 12.3) | 3.5(2.0, 4.8) | 1.0(1.0, 2.0) | 5.5(2.0, 9.8) |
-4.963 | -5.077 | -5.218 | -3.645 | ||
<0.01 | <0.01 | <0.01 | <0.01 |
Tab.3 Frequency of complications in elderly dialysis patients with conventional hemodialysis protocol ( M[P25, P75])
组别 | 例数 | 低血压 | 低血糖 | 肢体痉挛 | 高血压 |
---|---|---|---|---|---|
DN2组 | 20 | 19.5(16.5, 26.8) | 11.5(8.3, 13.0) | 9.5(8.0, 11.0) | 18.0(8.0, 35.5) |
NDN2组 | 20 | 9.5(6.0, 12.3) | 3.5(2.0, 4.8) | 1.0(1.0, 2.0) | 5.5(2.0, 9.8) |
-4.963 | -5.077 | -5.218 | -3.645 | ||
<0.01 | <0.01 | <0.01 | <0.01 |
组别 | 例数 | 低血压 | 低血糖 | 肢体痉挛 | 高血压 |
---|---|---|---|---|---|
NDN1组 | 20 | 3.5(2.3, 6.8) | 0.0(0.0, 0.8) | 0.0(0.0, 1.0) | 5.5(4.0, 16.0) |
NDN2组 | 20 | 9.5(6.0, 12.3) | 3.5(2.0, 4.8) | 1.0(1.0, 2.0) | 5.5(2.0, 9.8) |
-3.531 | -4.534 | -2.569 | -1.115 | ||
<0.01 | <0.01 | 0.010 | 0.265 |
Tab.4 Frequency of complications at different dialysis regimens in NDN group ( M [P25, P75])
组别 | 例数 | 低血压 | 低血糖 | 肢体痉挛 | 高血压 |
---|---|---|---|---|---|
NDN1组 | 20 | 3.5(2.3, 6.8) | 0.0(0.0, 0.8) | 0.0(0.0, 1.0) | 5.5(4.0, 16.0) |
NDN2组 | 20 | 9.5(6.0, 12.3) | 3.5(2.0, 4.8) | 1.0(1.0, 2.0) | 5.5(2.0, 9.8) |
-3.531 | -4.534 | -2.569 | -1.115 | ||
<0.01 | <0.01 | 0.010 | 0.265 |
组别 | 例数 | 低血压 | 低血糖 | 肢体痉挛 | 高血压 |
---|---|---|---|---|---|
DN1组 | 20 | 11.0(10.0, 15.8) | 5.0(4.0, 6.8) | 3.0(2.0, 5.8) | 10.0(2.0, 22.8) |
DN2组 | 20 | 19.5(16.5, 26.8) | 11.5(8.3, 13.0) | 9.5(8.0, 11.0) | 18.0(8.0, 35.5) |
-4.329 | -4.127 | -4.374 | -1.815 | ||
<0.01 | <0.01 | <0.01 | 0.047 |
Tab.5 Frequency of complications at different dialysis regimens in DN group ( M [P25, P75])
组别 | 例数 | 低血压 | 低血糖 | 肢体痉挛 | 高血压 |
---|---|---|---|---|---|
DN1组 | 20 | 11.0(10.0, 15.8) | 5.0(4.0, 6.8) | 3.0(2.0, 5.8) | 10.0(2.0, 22.8) |
DN2组 | 20 | 19.5(16.5, 26.8) | 11.5(8.3, 13.0) | 9.5(8.0, 11.0) | 18.0(8.0, 35.5) |
-4.329 | -4.127 | -4.374 | -1.815 | ||
<0.01 | <0.01 | <0.01 | 0.047 |
组别 | 例数 | 血白蛋白(g/L) | 血红蛋白(g/L) | URR(%) |
---|---|---|---|---|
DN1组 | 20 | 40.80±2.84 | 103.50±15.37 | 56.10±8.01 |
NDN1组 | 20 | 42.75±4.56 | 109.90±9.71 | 63.95±6.05 |
-1.622 | -1.574 | -3.499 | ||
0.113 | 0.125 | 0.051 |
Tab.6 Comparison of nutritional indicators and dialysis effects using individualized dialysis regimens in elderly ($\bar{x}±s$)
组别 | 例数 | 血白蛋白(g/L) | 血红蛋白(g/L) | URR(%) |
---|---|---|---|---|
DN1组 | 20 | 40.80±2.84 | 103.50±15.37 | 56.10±8.01 |
NDN1组 | 20 | 42.75±4.56 | 109.90±9.71 | 63.95±6.05 |
-1.622 | -1.574 | -3.499 | ||
0.113 | 0.125 | 0.051 |
组别 | 例数 | 血白蛋白(g/L) | 血红蛋白(g/L) | URR(%) |
---|---|---|---|---|
DN2组 | 20 | 42.40±4.17 | 108.60±13.80 | 59.70±5.28 |
NDN2组 | 20 | 42.65±2.92 | 112.90±7.81 | 63.15±5.86 |
0.658 | -1.213 | -1.956 | ||
0.514 | 0.235 | 0.058 |
Tab.7 Comparison of nutritional indicators and dialysis effect in elderly patients undergoing dialysis under conventional dialysis scheme ($\bar{x}±s$)
组别 | 例数 | 血白蛋白(g/L) | 血红蛋白(g/L) | URR(%) |
---|---|---|---|---|
DN2组 | 20 | 42.40±4.17 | 108.60±13.80 | 59.70±5.28 |
NDN2组 | 20 | 42.65±2.92 | 112.90±7.81 | 63.15±5.86 |
0.658 | -1.213 | -1.956 | ||
0.514 | 0.235 | 0.058 |
组别 | 例数 | 血白蛋白(g/L) | 血红蛋白(g/L) | URR(%) |
---|---|---|---|---|
DN1组 | 20 | 40.80±2.84 | 103.50±15.37 | 56.10±8.01 |
DN2组 | 20 | 43.40±4.17 | 108.60±13.80 | 59.70±5.28 |
-2.304 | -1.104 | -1.679 | ||
0.057 | 0.277 | 0.101 |
Tab.8 Comparison of nutritional indicators and dialysis effect in DN group under different dialysis schemes ($\bar{x}±s$)
组别 | 例数 | 血白蛋白(g/L) | 血红蛋白(g/L) | URR(%) |
---|---|---|---|---|
DN1组 | 20 | 40.80±2.84 | 103.50±15.37 | 56.10±8.01 |
DN2组 | 20 | 43.40±4.17 | 108.60±13.80 | 59.70±5.28 |
-2.304 | -1.104 | -1.679 | ||
0.057 | 0.277 | 0.101 |
组别 | 例数 | 血白蛋白(g/L) | 血红蛋白(g/L) | URR(%) |
---|---|---|---|---|
NDN1组 | 20 | 42.55±4.56 | 109.90±9.71 | 63.95±6.05 |
NDN2组 | 20 | 42.65±2.92 | 112.90±7.81 | 63.15±5.86 |
0.083 | -1.077 | 0.425 | ||
0.935 | 0.288 | 0.673 |
Tab.9 Comparison of nutritional indicators and dialysis effects under different dialysis regimens in NDN group ($\bar{x}±s$)
组别 | 例数 | 血白蛋白(g/L) | 血红蛋白(g/L) | URR(%) |
---|---|---|---|---|
NDN1组 | 20 | 42.55±4.56 | 109.90±9.71 | 63.95±6.05 |
NDN2组 | 20 | 42.65±2.92 | 112.90±7.81 | 63.15±5.86 |
0.083 | -1.077 | 0.425 | ||
0.935 | 0.288 | 0.673 |
[1] | 李慧凛, 齐尔, 蒋更如, 等. 终末期糖尿病肾病血液透析和腹膜透析预后的比较研究[J]. 中国血液净化, 2013, 12(5):238-242. |
[2] | Frankel AH, Kazempour-Ardebili S, Bedi R, et al. Mana-gement of adults with diabetes on the haemodialysis unit: Summary of guidance from the joint british diabetes societies and the renal association[J]. Diabet Med, 2018, 35(8):1018-1026. |
[3] | Tao QR, Chu YM, Wei L, et al. Antiangiogenic therapy in diabetic nephropathy: A double-edged sword[J]. Mol Med Rep, 2021, 23(4):260. |
[4] | Wang F, Yang C, Long J, et al. Executive summary for the 2015 annual data report of the China kidney disease network (CK-NET)[J]. Kidney Int, 2019, 95(3):501-505. |
[5] | Saran R, Robinson B, Abbott KC, et al. US renal data system 2017 annual data report:Epidemiology of kidney disease in the united states[J]. Am J Kidney Dis, 2018, 71(3 Suppl1):A7. |
[6] | Bijay B, Manish S, Mayank MK, et al. Spectrum of compli- cations in chronic kidney disease patients undergoing maintenance hemodialysis: An experience of a tertiary care center in Nepal[J]. Saudi J Kidney Dis Transpl, 2019, 30(1):208-214. |
[7] | 马晓华, 周亚男, 王荣荣, 等. 持续低效缓慢血液透析治疗终末期糖尿病肾病临床观察[J]. 解放军医药杂志, 2019, 31(4):57 -59. |
[8] |
Henry OO, Emmanuel EE, Sidney KO, et al. Intradialysis blood pressure changes among chronic kidney disease patients on maintenance haemo- dialysis in a tertiary hospital south - south Nigeria: A 2 year retrospective study[J]. Pan Afr Med J, 2019, 33:91.
doi: 10.11604/pamj.2019.33.91.17000 pmid: 31489069 |
[9] | 张超, 李芹. 血液透析治疗老年糖尿病肾病患者的安全性分析[J]. 理论与实践, 2019, 32(16):2573-2575. |
[10] | 潘翠萍, 周参新, 施善芬. 终末期糖尿病肾病患者行血液透析与腹膜透析的疗效及预后COX回归分析[J]. 现代实用医学, 2020, 32(3):311-313. |
[11] | Brown EA, Johansson L. Epidemiology and management of end-stage renal diseasse in the elderly[J]. Nat Rev Nephrol, 2011, 7(10):591-598. |
[12] | 陈磊, 方莉, 吴碧金, 等. 血液透析治疗糖尿病肾病终末期疗效和并发症分析[J]. 糖尿病新世界, 2018, 21(9):35-36. |
[13] | 李杰, 何旦明, 陈新育. 对比分析终末期糖尿病肾病与非糖尿病肾病血液透析患者的并发症发生情况[J]. 当代医学, 2020, 26 (16):109-111. |
[14] | 钱锋, 张玉丽, 郭颖, 等. 终末期糖尿病肾病与非糖尿病肾病血液透析患者并发症对比分析[J]. 中国现代药物应用, 2018, 12 (22):55-57. |
[15] | 陈独立, 陈金新, 陈志忠. 糖尿病肾病与非糖尿病肾病血液透析中急慢性并发症治疗效果[J]. 糖尿病新世界, 2121, 24(24):38 -40. |
[16] | Chan K, Moe SM, Saran R, et al. The cardiovascular-dia-lysis nexus: The transition to dialysis is a treacherous time for the heart[J]. Eur Heart J, 2021, 42(13):1244-1253. |
[17] | 罗洋. 维持性血液透析患者的血压控制目标研究进展[J]. 当代医药卫生, 2020, 36(21):3453-3457. |
[18] | 费丹峰, 朱鸣, 任凌燕, 等. 不同透析方式对终末期糖尿病肾病患者Klotho蛋白, FGF-23及颈动脉内膜中层厚度的影响[J]. 广东医学, 2020, 41(21):2192-2195. |
[19] | 曾华韫, 彭红云, 高翠翠, 等. 糖尿病肾病血液透析患者生存质量影响因素探讨[J]. 卫生职业教育, 2020, 38(17):143-145. |
[20] | 贾文姬, 李路玲, 秦晓新, 等. 糖尿病肾病维持性血液透析患者低血糖发生情况及其影响因素的Logistic回归分析[J]. 现代生物医学进展, 2023, 23(8):1473-1476. |
[21] | Li WH, Yin YM, Chen H, et al. Clinical research on indivi- dualized hemodialysis preventing unconventional hypoten- sion in diabetic nephropathy patient[J]. Int J Artif Organs, 2020, 43(4):229-233. |
[22] | 吴琼皎, 常玉萍, 李晓. 个体化血液透析在慢性肾功能衰竭尿毒症期治疗中的应用效果[J]. 临床医学, 2023, 43(10):66-68. |
[23] | 焦占峰, 张宜明, 马小芬, 等. 不同超滤率对糖尿病肾病患者维持性血液透析中低血压及心血管死亡发生率影响[J]. 临床军医杂志, 2021, 49(9):1002-1004. |
[24] | 方蓉, 龚红英, 段智宇, 等. 透析后体位性低血压对老年维持性血液透析患者生存的影响[J]. 国际移植与血液净化杂志, 2020, 18(2):23-26. |
[25] | 李冰, 张迎春, 孙景. 持续低效缓慢血液透析治疗终末期糖尿病肾病的临床有效性分析[J]. 当代医学, 2021, 27(33):156-158. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||